Four investments form Arch Venture Becker’s has covered since Sept. 13:
- Arch Venture co-led the $18 million series A funding round for Protillion Biosciences. The company works to optimize and identify new protein therapeutics, according to a Dec. 19 Protillion news release.
- Arch led the $75 million series C financing round for Synchron, a brain-computer interface company. Bezos Expeditions, the investment firm of Amazon founder Jeff Bezos, and Gates Frontier, Microsoft founder Bill Gates’ investment fund, joined in the round.
- Arch and General Catalyst co-led a $32 million seed funding round for Rippl, a mental health tech company focused on the needs of older patients.
- Arch co-led a $72.5 million series A funding round for Pretzel Therapeutics, a company that uses mitochondrial biology to treat disease.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.